Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hyperhydration on pemetrexed pharmacokinetics
NL-OMON44619Recruiting
- Sponsor
- Zanob Pharmacy
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pemetrexed in non-small cell lung cancer (NSCLC) and mesothelioma, sponsored by Zanob Pharmacy. Started Mar 2018; status: recruiting.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)mesothelioma
Beyond the preview
Go deeper on NL-OMON44619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44619.